Novocell, Inc.

Authors: Lewis, Alan J1; Carpenter, Melissa; Robins, Allan; Baetge, Emmanuel

Source: Regenerative Medicine, Volume 2, Number 6, November 2007 , pp. 973-978(6)

Publisher: Future Medicine

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Novocell, Inc. is a stem cell engineering company creating, delivering and commercializing cell and drug therapies for diabetes and other chronic diseases. The use of human embryonic stem cells provides a scalable source of any differentiated lineage that has potential for cell replacement therapy, as well as tools for drug discovery to create regenerative medicines.

Document Type: Research article

DOI: 10.2217/17460751.2.6.973

Affiliations: 1: Novocell, Inc., 3550 General Atomics Court, Building 2, Room 503, San Diego, CA 92121, USA., Email: alewis@novocell.com

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$73.00 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A